Product nameAnti-CD52 antibody [EPR3153(2)]
See all CD52 primary antibodies
DescriptionRabbit monoclonal [EPR3153(2)] to CD52
Tested applicationsSuitable for: WB, IPmore details
Unsuitable for: IHC-P
Species reactivityReacts with: Mouse
Does not react with: Rat, Human
Synthetic peptide within Mouse CD52 aa 1-100. The exact sequence is proprietary.
- Mouse thymus and spleen lysates.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Storage instructionsShipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
Storage bufferpH: 7.20
Preservative: 0.05% Sodium azide
Constituents: 0.1% BSA, 40% Glycerol, 9.85% Tris glycine, 50% Tissue culture supernatant
Concentration information loading...
PurityTissue culture supernatant
Our Abpromise guarantee covers the use of ab125071 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/10000. Detects a band of approximately 13-29 kDa (predicted molecular weight: 8 kDa).|
|IP||1/10 - 1/100.|
FunctionMay play a role in carrying and orienting carbohydrate, as well as having a more specific role.
Cellular localizationCell membrane.
- Information by UniProt
- Cambridge pathology 1 antigen antibody
- CAMPATH 1 antibody
- CAMPATH 1 antigen antibody
All lanes : Anti-CD52 antibody [EPR3153(2)] (ab125071) at 1/1000 dilution
Lane 1 : Mouse thymus lysate
Lane 2 : Mouse spleen lysate
Lysates/proteins at 10 µg per lane.
All lanes : standard HRP labelled goat anti-rabbit at 1/2000 dilution
Developed using the ECL technique.
Predicted band size: 8 kDa
ab125071 has not yet been referenced specifically in any publications.